Cynthia Adams

Jul 10, 2017  |  Think Magazine

Pragya Adhikari

Pragya Adhikari from Nepal is trying to breed a tomato that is tastier and more resistant to plant diseases.

Jul 10, 2017  |  Think Magazine

Therese Anne Fowler

After graduating from NC State's MFA program, Therese Fowler experienced the publication of many successful works--including Z: A Novel of Zelda Fitzgerald, recently adapted as an Amazon original series.

Jul 10, 2017  |  Innovative Research

Sophia Webster

Graduate student Sophia Webster is trying to fight Zika by engineering mosquitoes that won't spread the disease.

Jul 10, 2017  |  Think Magazine

Brianna Hess Massie

Brianna Massie Hess is looking for simple solutions to help hog producers deal with lagoon waste.

Nov 29, 2016

Magdalena Sorger

Magadalena Sorger was on the path to an MBA degree and a chance to enter the high-stakes world of business ... until she discovered ants.

Nov 29, 2016

Douglas Shoemaker

Douglas Shoemaker, who completed his doctorate this year, trained at NC State’s Center for Geospatial Analytics before accepting a directorship at the Center for Applied GIS at UNC-Charlotte on July 1 this year.

Nov 29, 2016

Water Warrior: Catalina Lopez-Velandia

Before completing her master's degree earlier this year, Catalina Lopez-Velandia received third place at the Graduate Student Research Symposium for her research concerning 1,4-dioxane in the Cape Fear River watershed.

Nov 29, 2016

Alexander Kapatos

Graduate student Alexander Kapatos’ research in cancer immunotherapy is potentially a breakthrough therapy that may one day lead to the news headline: Cancer Vaccine Targets Lymphoma.

Nov 29, 2016

Charisse Holmes

As a graduate student at NC State, Charisse Holmes investigated adverse health triggers which can occur in ubiquitous consumer products. This summer, she launched her toxicology career, working in drug safety.

Nov 29, 2016

Amanda Walter: Proud Graduate, Proud Woman

Amanda Walter believes that graduate studies at NC State lent her scientific credibility and eventual access “to the very people who determined whether or not pharmaceutical companies can market biosimilar drugs.”